| CASE REPORT |
|
| Year : 2018 | Volume
: 17
| Issue : 1 | Page : 40-42 |
|
|
Sparfloxacin-induced nail pigmentation: A case of fixed drug eruption?
Husain Yahya
Dermatology Unit, Department of Medicine, Barau Dikko Teaching Hospital, Kaduna, Nigeria
Correspondence Address:
Dr. Husain Yahya
Dermatology Unit, Department of Medicine, Barau Dikko Teaching Hospital, P.O. Box 9727, Kaduna
Nigeria
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/aam.aam_16_17
|
|
|
Sparfloxacin, a synthetic, second generation, broad spectrum aminodifluoroquinolone antibiotic, has excellent penetration into respiratory tissues and has good activity against Gram-positive, Gram-negative, and atypical bacteria. Although it is indicated for the treatment of adult community-acquired pneumonia and acute exacerbation of chronic bronchitis, its use has been limited by phototoxicity which is more common with it than with other quinolones. We report a case of a 20-year-old Nigerian woman who developed a diffuse blue-black nail pigmentation of thumb and big toe nails, 2 weeks after completing therapy with sparfloxacin, and a recurrence of the pigmentation in the same nails 1 year after taking the drug again. We think this is likely a case of subungual fixed drug eruption. We briefly discuss the causes and mechanisms of drug-induced nail pigmentation in general.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
